Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Gilead Sciences (GILD) Dips More Than Broader Market: What You Should Know
Gilead Sciences (GILD) Dips More Than Broader Market: What You Should Know
FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
7 Value Stocks to Buy at a 52-Week Low in March
Gilead bets on Xilio cancer drug as biotech restructures
Winn Awards Help Physicians Solve Healthcare Disparities
20 Biggest Health Care Companies in Australia, 2024
Gilead Sciences (GILD) Stock Moves -0.04%: What You Should Know
Gilead Sciences (GILD) Stock Moves -0.04%: What You Should Know
Gilead Sciences Announces Completion of Acquisition of CymaBay
Why Is Axsome (AXSM) Down 4% Since Last Earnings Report?
Why Is Axsome (AXSM) Down 4% Since Last Earnings Report?
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
Gilead Sciences (GILD) Rises But Trails Market: What Investors Should Know
Gilead Sciences (GILD) Rises But Trails Market: What Investors Should Know
Gilead Helps Launch Türkiye’s First HIV Testing Week
Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.